AMYLIN PHARMACEUTICALS INC·4

Jun 4, 6:06 PM ET

AMYLIN PHARMACEUTICALS INC 4

4 · AMYLIN PHARMACEUTICALS INC · Filed Jun 4, 2007

Insider Transaction Report

Form 4
Period: 2007-06-01
BARON ALAIN D
Sr VP Research
Transactions
  • Exercise/Conversion

    Common Stock

    2007-06-01$10.94/sh+1,000$10,94016,847 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2007-06-013,00054,616 total
    Exercise: $7.19Exp: 2009-12-08Common Stock (3,000 underlying)
  • Exercise/Conversion

    Common Stock

    2007-06-01$7.19/sh+3,000$21,56318,847 total
  • Sale

    Common Stock

    2007-06-01$46.16/sh3,000$138,48015,847 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2007-06-011,0004,042 total
    Exercise: $10.94Exp: 2012-06-28Common Stock (1,000 underlying)
  • Sale

    Common Stock

    2007-06-01$46.16/sh1,000$46,16015,847 total
Footnotes (3)
  • [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]15,275 options vested on 12/08/2000, and daily after that, until all the 95,000 options were completely vested on 12/08/2003.
  • [F3]2,500 options vested on 06/28/02, and monthly after that, until all the 10,000 options were completely vested on 06/28/06.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT